Delivery Order SPE2DB25D3012-SPE2DB25FWYCB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a ceiling value of $1,303.03 under a firm fixed-price arrangement. The delivery order carries an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, consistent with the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, with a contract value of $4,118.65. This delivery order represents a firm fixed price procurement with an ultimate completion date of September 18, 2025, and utilizes no set-aside provisions, indicating competitive award procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $2,890.58, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags with a ceiling value of $7,765.88. This non-competitive delivery order, issued on September 9, 2025, represents a firm fixed-price pharmaceutical procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,569.36 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 29, 2025. This contract employs firm fixed price pricing and represents a non-set-aside, competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and a key distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a common broad-spectrum antibiotic used extensively in military and federal healthcare systems. This firm fixed price delivery order, valued at $9,528.22, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $1,417.62 and is scheduled for completion by August 22, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 1 GM-D5W bags valued at $1,234.64 under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,871.80 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. Awarded on November 5, 2025, with completion targeted for November 6, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYCBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a commonly used broad-spectrum antibiotic. The contract, valued at $5,210.50 with a firm fixed-price structure, is scheduled for completion by June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen's federal contract portfolio demonstrates consistent success in delivering critical medications and medical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare systems across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 6/18/25 |